Physical Medicine & Rehabilitation, Pain Medicine · Lake Worth, FL
NPI
1831143312
Since 2006
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2290 10th Ave N Ste 201
Lake Worth, FL, 33461
Phone (561) 296-2220
Groups this clinician bills Medicare through
Medicare paid, 2024
$193K
2,573 services
Medicare patients, 2024
257
Average age 69
Drug cost, 2024
$805K
14,331 prescriptions
Company payments, 2025
$4,322
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stuart B Krost was code 99213 (office e&m - established), 847 times for 171 patients. In total Stuart B Krost billed 2,573 services in 42 codes, and Medicare paid $193K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 847 | 171 | $67.64 | $57K |
| 99214 Office E&M - Established | Office | 569 | 155 | $99.31 | $57K |
| 80305 Drug Tests | Office | 246 | 116 | $12.35 | $3,038 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 225 | 13 | $0.11 | $23.65 |
| 95886 Electrical Nerve Conductivity | Office | 105 | 47 | $74.63 | $7,836 |
| 95921 Electrical Nerve Conductivity | Office | 69 | 67 | $69.35 | $4,785 |
| 95923 Electrical Nerve Conductivity | Office | 69 | 67 | $96.37 | $6,650 |
| 93922 Duplex Scan - Extremity Arteries | Office | 65 | 63 | $65.36 | $4,248 |
| 99204 Office E&M - New | Office | 57 | 57 | $123.00 | $7,011 |
| 64493 Nerve Block Injection - Back | Office | 39 | 28 | $208.02 | $8,113 |
| 64494 Nerve Block Injection - Back | Office | 38 | 28 | $109.48 | $4,160 |
| 95911 Electrical Nerve Conductivity | Office | 26 | 26 | $153.17 | $3,982 |
| 95885 Electrical Nerve Conductivity | Office | 22 | 11 | $44.31 | $975 |
| 99215 Office E&M - Established | Office | 22 | 17 | $141.59 | $3,115 |
| 20553 Musculoskeletal | Office | 20 | 17 | $48.77 | $975 |
By year: 2022 $296K for 3,596 services; 2023 $273K for 3,375 services; 2024 $193K for 2,573 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 246 | 116 | $12.35 | $3,038 |
Medicare prescription drug claims, 2024
In 2024, the drug Stuart B Krost prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 3,234 prescriptions and refills. In total Stuart B Krost wrote 14,331 Medicare prescriptions that cost $805K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 3,234 | 3,237 | 448 | $101K |
| Oxycodone Hcl Generic | 1,500 | 1,504 | 211 | $24K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,442 | 1,442 | 251 | $30K |
| Gabapentin Generic | 1,086 | 1,142 | 203 | $9,660 |
| Diclofenac Sodium Generic | 784 | 845 | 245 | $8,260 |
| Cyclobenzaprine Hcl Generic | 704 | 743 | 133 | $2,424 |
| Tramadol Hcl Generic | 617 | 622 | 137 | $4,362 |
| Baclofen Generic | 553 | 571 | 120 | $2,656 |
| Tizanidine Hcl Generic | 533 | 575 | 103 | $2,037 |
| Morphine Sulfate Er Morphine Sulfate | 427 | 429 | 73 | $17K |
| Pregabalin Generic | 379 | 398 | 70 | $5,285 |
| Movantik Naloxegol Oxalate | 262 | 274 | 69 | $110K |
| Naloxone Hcl Generic | 255 | 259 | 217 | $20K |
| Omeprazole Generic | 182 | 197 | 47 | $943 |
| Ibuprofen Generic | 178 | 208 | 44 | $728 |
Brand drugs: 659 claims; generic drugs: 13,672 claims; opioid claims: 7,983.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stuart B Krost $4,322 ($4,322 in general payments such as food, travel and fees) from 7 companies. The largest payer was BIOTRONIK NRO, Inc. with $3,408.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.